INTERMITTENT RISEDRONATE PREVENTS BONE LOSS IN WOMEN WITH ARTIFICIAL MENOPAUSE INDUCED BY CHEMOTHERAPY OF BREAST-CANCER

被引：0
|
作者：
DELMAS, PD
HARDOUIN, C
CONFAVREUX, E
HARDY, P
BREMOND, A
机构：
[1] UNIV LYON 1,INSERM,U403,F-69365 LYON 2,FRANCE
[2] UNIV LYON 1,CTR LEONE BERARD,F-69365 LYON 2,FRANCE
[3] PROCTER & GAMBLE PH,PARIS,FRANCE
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [41] CONDITIONED EMOTIONAL DISTRESS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER
    JACOBSEN, PB
    BOVBJERG, DH
    SCHWARTZ, MD
    HUDIS, CA
    GILEWSKI, TA
    NORTON, L
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1995, 63 (01) : 104 - 114
  • [42] Risedronate Prevents Anastrozole-Induced Bone Loss In The IBIS-II Prevention Trial.
    Sestak, Ivana
    Singh, Shalini
    Cuzick, Jack
    Blake, Glen
    Patel, Rajesh
    Coleman, Rob
    Dowsett, Mitch
    Forbes, John F.
    Howell, Anthony
    Eastell, Richard
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S110 - S110
  • [43] Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    Greenspan, S. L.
    Vujevich, K. T.
    Brufsky, A.
    Lembersky, B. C.
    van Londen, G. J.
    Jankowitz, R. C.
    Puhalla, S. L.
    Rastogi, P.
    Perera, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (06) : 1857 - 1864
  • [44] Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    S. L. Greenspan
    K. T. Vujevich
    A. Brufsky
    B. C. Lembersky
    G. J. van Londen
    R. C. Jankowitz
    S. L. Puhalla
    P. Rastogi
    S. Perera
    [J]. Osteoporosis International, 2015, 26 : 1857 - 1864
  • [45] BISPHOSPHONATE RISEDRONATE REDUCES METASTATIC HUMAN BREAST-CANCER BURDEN IN BONE IN NUDE-MICE
    SASAKI, A
    BOYCE, BF
    STORY, B
    WRIGHT, KR
    CHAPMAN, M
    BOYCE, R
    MUNDY, GR
    YONEDA, T
    [J]. CANCER RESEARCH, 1995, 55 (16) : 3551 - 3557
  • [46] CE Cognitive Effects of Chemotherapy-Induced Menopause in Breast Cancer
    Vearncombe, Katharine J.
    Rolfe, Margaret
    Andrew, Brooke
    Pachana, Nancy A.
    Wright, Margaret
    Beadle, Geoffrey
    [J]. CLINICAL NEUROPSYCHOLOGIST, 2011, 25 (08) : 1295 - 1313
  • [47] Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer
    Hines, Stephanie L.
    Mincey, Betty Anne
    Sloan, Jeff A.
    Thomas, Sachdev P.
    Chottiner, Elaine
    Loprinzi, Charles L.
    Carlson, Mark D.
    Atherton, Pamela J.
    Salim, Muhammad
    Perez, Edith A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1047 - 1053
  • [48] Influence of chemotherapy on bone in premenopausal women with breast cancer
    Hadji, P.
    Maskow, C.
    Kalder, M.
    Ziller, V
    Wagner, U.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S276 - S276
  • [49] Daily risedronate prevents bone loss in osteopenic, postmenopausal women:: A 2-year multicenter trial in europe
    Valmaki, M.
    Heikkinen, J.
    Munoz-Torres, M.
    Mulder, H.
    Ofjord, E. S.
    Toss, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S60 - S61
  • [50] PREOCCUPATION ABOUT HAIR LOSS IN BREAST-CANCER PATIENTS BEFORE CHEMOTHERAPY
    TOLEDO, M
    FERRERO, J
    BARRETO, P
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 1992, 27 (3-4) : 642 - 642
12345